Acorda Therapeutics v. Alkermes PLC — Second Circuit Upholds Arbitral Limit on Post-Patent Royalty Recovery
The Second Circuit affirmed an arbitral award giving Acorda only $16.5M of the ~$82M in post-expiration royalties it paid on an Ampyra MS drug patent, holding Brulotte/Kimble do not mandate full restitution and that New York’s Voluntary-Pay Doctrine bars recovery of royalties paid without contempora